Loeb S - Search Results

1

The case for open radical prostatectomy.

Schaeffer EM, Loeb S, Walsh PC. Schaeffer EM, et al. Among authors: loeb s. Urol Clin North Am. 2010 Feb;37(1):49-55, Table of Contents. doi: 10.1016/j.ucl.2009.11.008. Urol Clin North Am. 2010. PMID: 20152519 Review.

2

A prospective study of laparoscopic radical nephrectomy for T1 tumors--is transperitoneal, retroperitoneal or hand assisted the best approach?

Nadler RB, Loeb S, Clemens JQ, Batler RA, Gonzalez CM, Vardi IY. Nadler RB, et al. Among authors: loeb s. J Urol. 2006 Apr;175(4):1230-3; discussion 1234. doi: 10.1016/S0022-5347(05)00686-5. J Urol. 2006. PMID: 16515966 Clinical Trial.

3

Management of the complications of external beam radiotherapy and brachytherapy.

Loeb S, Nadler RB. Loeb S, et al. Curr Urol Rep. 2006 May;7(3):200-8. doi: 10.1007/s11934-006-0022-0. Curr Urol Rep. 2006. PMID: 16630523 Review.

4

Lymphovascular invasion in radical prostatectomy specimens: prediction of adverse pathologic features and biochemical progression.

Loeb S, Roehl KA, Yu X, Antenor JA, Han M, Gashti SN, Yang XJ, Catalona WJ. Loeb S, et al. Urology. 2006 Jul;68(1):99-103. doi: 10.1016/j.urology.2006.02.004. Epub 2006 Jun 27. Urology. 2006. PMID: 16806410

5

Comparison of methods for calculating prostate specific antigen velocity.

Yu X, Han M, Loeb S, Gashti SN, Yeh JT, Roehl KA, Catalona WJ. Yu X, et al. Among authors: loeb s. J Urol. 2006 Dec;176(6 Pt 1):2427-31; discussion 2431. doi: 10.1016/j.juro.2006.08.006. J Urol. 2006. PMID: 17085120

6

Survival results in patients with screen-detected prostate cancer versus physician-referred patients treated with radical prostatectomy: early results.

Roehl KA, Eggener SE, Loeb S, Smith ND, Antenor JA, Catalona WJ. Roehl KA, et al. Among authors: loeb s. Urol Oncol. 2006 Nov-Dec;24(6):465-71. doi: 10.1016/j.urolonc.2005.11.039. Urol Oncol. 2006. PMID: 17138126

7

Does body mass index affect preoperative prostate specific antigen velocity or pathological outcomes after radical prostatectomy?

Loeb S, Yu X, Nadler RB, Roehl KA, Han M, Hawkins SA, Catalona WJ. Loeb S, et al. J Urol. 2007 Jan;177(1):102-6; discussion 106. doi: 10.1016/j.juro.2006.08.097. J Urol. 2007. PMID: 17162013

8

Intermediate-term potency, continence, and survival outcomes of radical prostatectomy for clinically high-risk or locally advanced prostate cancer.

Loeb S, Smith ND, Roehl KA, Catalona WJ. Loeb S, et al. Urology. 2007 Jun;69(6):1170-5. doi: 10.1016/j.urology.2007.02.054. Urology. 2007. PMID: 17572209 Clinical Trial.

9

Pathological features after radical prostatectomy in potential candidates for active monitoring.

Griffin CR, Yu X, Loeb S, Desireddi VN, Han M, Graif T, Catalona WJ. Griffin CR, et al. Among authors: loeb s. J Urol. 2007 Sep;178(3 Pt 1):860-3; discussion 863. doi: 10.1016/j.juro.2007.05.016. Epub 2007 Jul 16. J Urol. 2007. PMID: 17631347

10

Prostate specific antigen velocity in men with total prostate specific antigen less than 4 ng/ml.

Loeb S, Roehl KA, Nadler RB, Yu X, Catalona WJ. Loeb S, et al. J Urol. 2007 Dec;178(6):2348-52; discussion 2352-3. doi: 10.1016/j.juro.2007.08.016. Epub 2007 Oct 22. J Urol. 2007. PMID: 17936844

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results